Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evaluating the use of social contact data to produce age-specific forecasts of SARS-CoV-2 incidence

View ORCID ProfileJames D Munday, View ORCID ProfileSam Abbott, View ORCID ProfileSophie Meakin, View ORCID ProfileSebastian Funk
doi: https://doi.org/10.1101/2022.12.02.22282935
James D Munday
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, UK
2Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James D Munday
  • For correspondence: james.munday{at}lshtm.ac.uk
Sam Abbott
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, UK
2Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sam Abbott
Sophie Meakin
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, UK
2Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sophie Meakin
Sebastian Funk
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, UK
2Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sebastian Funk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Short-term forecasts can provide predictions of how an epidemic will change in the near future and form a central part of outbreak mitigation and control. Renewal-equation based models are increasingly popular. They infer key epidemiological parameters from historical epidemiological data and forecast future epidemic dynamics without requiring complex mechanistic assumptions. However, these models typically ignore interaction between age-groups, partly due to challenges in parameterising a time varying interaction matrix. Social contact data collected regularly by the CoMix survey during the COVID-19 epidemic in England, provide a means to inform interaction between age-groups in real-time.

We developed an age-specific forecasting framework and applied it to two age-stratified time-series: incidence of SARS-CoV-2 infection, estimated from a national infection and antibody prevalence survey; and, reported cases according to the UK national COVID-19 dashboard. Jointly fitting our model to social contact data from the CoMix study, we inferred a time-varying next generation matrix which we used to project infections and cases in the four weeks following each of 29 forecast dates between October 2021 and November 2022. We evaluated the forecasts using proper scoring rules and compared performance with three other models with alternative data and specifications alongside two naive baseline models.

Overall, incorporating age-interaction improved forecasts of infections and the CoMix-data-informed model was the best performing model at time horizons between two and four weeks. However, this was not true when forecasting cases. We found that age-group-interaction was most important for predicting cases in children and older adults. The contact-data-informed models performed best during the winter months of 2020 - 2021, but performed comparatively poorly in other periods. We highlight challenges regarding the incorporation of contact data in forecasting and offer proposals as to how to extend and adapt our approach, which may lead to more successful forecasts in future.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was partly funded by an Office for National Statistics COVID-19 Infection Survey Analysis grant PU-20-0205(c): JDM. This work was partly funded by the Wellcome Trust 210758/Z/18/Z: JDM and SF

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study used ONLY openly available human data located at: Contact Matrices: https://doi.org/10.5281/zenodo.7351951 COVID-19 Cases: https://coronavirus.data.gov.uk COVID-19 infection survey: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/25november2022

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Case data is available on thu UK Covid-19 Dashboard https://coronavirus.data.gov.uk Infection and antibody prevalence data is available from the Covid-19 infection survey website https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/25november2022 and contact matrices are available from the CoMix online repository https://doi.org/10.5281/zenodo.7351951.

Data Availability

Case data is available on thu UK Covid-19 Dashboard https://coronavirus.data.gov.uk Infection and antibody prevalence data is available from the Covid-19 infection survey website https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/25november2022 and contact matrices are available from the CoMix online repository https://doi.org/10.5281/zenodo.7351951.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted December 03, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evaluating the use of social contact data to produce age-specific forecasts of SARS-CoV-2 incidence
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluating the use of social contact data to produce age-specific forecasts of SARS-CoV-2 incidence
James D Munday, Sam Abbott, Sophie Meakin, Sebastian Funk
medRxiv 2022.12.02.22282935; doi: https://doi.org/10.1101/2022.12.02.22282935
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Evaluating the use of social contact data to produce age-specific forecasts of SARS-CoV-2 incidence
James D Munday, Sam Abbott, Sophie Meakin, Sebastian Funk
medRxiv 2022.12.02.22282935; doi: https://doi.org/10.1101/2022.12.02.22282935

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)